(Q44524352)

3 December 2017

Effects of ondansetron in early- versus late-onset alcoholics: a prospective, open-label study (English)

1 reference

3 December 2017

1

Henry R Kranzler

1 reference

3 December 2017

Amira Pierucci-Lagha

2

1 reference

PubMed ID

12878921

3 December 2017

Richard Feinn

series ordinal

3

1 reference

PubMed ID

12878921

3 December 2017

Carlos Hernandez-Avila

series ordinal

4

1 reference

3 December 2017

1 July 2003

1 reference

Alcoholism: Clinical and Experimental Research

3 December 2017

1 reference

3 December 2017

27

1 reference

3 December 2017

7

1 reference

3 December 2017

1150-1155

1 reference

Development and initial validation of a measure of drinking urges in abstinent alcoholics

3 December 2017

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000075547.77464.76

A multi-site study of alcohol subtypes: classification and overlap of unidimensional and multi-dimensional typologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000075547.77464.76

Specific decreases in ethanol- but not water-reinforced responding produced by the 5-HT3 antagonist ICS 205-930.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000075547.77464.76

Attenuation of some alcohol-induced mood changes and the desire to drink by 5-HT3 receptor blockade: a preliminary study in healthy male volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000075547.77464.76

Age of onset as a discriminator between alcoholic subtypes in a treatment-seeking outpatient population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000075547.77464.76

Ondansetron reduces the craving of biologically predisposed alcoholics

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000075547.77464.76

Drugs of abuse: anatomy, pharmacology and function of reward pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000075547.77464.76

Utility of a new assay for carbohydrate-deficient transferrin (Biorad %CDT TIA) to monitor abstinence during a treatment outcome study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000075547.77464.76

Clinical efficacy of the 5-HT3 antagonist ondansetron in alcohol abuse and dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000075547.77464.76

Ondansetron alters human alcohol intoxication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000075547.77464.76

Effect of the 5-HT3 antagonist ondansetron on voluntary ethanol intake in rats and mice maintained on a limited access procedure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000075547.77464.76

Antagonism of 5-HT3 receptors attenuates the effects of ethanol on extracellular dopamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000075547.77464.76

10.1097/01.ALC.0000075547.77464.76

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference

PubMed ID

12878921